Daniel E. Grosz, M.D. practices integrative holistic psychiatry in Encino, in the San Fernando Valley. Dr. Grosz specializes in the treatment of children, adolescents and adults with psychiatric disorders. He is certified by the American Board of Psychiatry and Neurology, and the American Board of Holistic Medicine.

Dr. Grosz integrates conventional psychotherapeutic and psychopharmacologic treatments with complementary approaches with the goal of helping his clients achieve an optimal mental health and a balanced lifestyle.

Dr. Daniel Grosz is originally from Argentina. He completed his undergraduate education and medical school at the University of Buenos Aires. He completed an internship and a general psychiatry residency at hospitals affiliated to the University of Tel Aviv in Israel. Subsequently, he completed a fellowship in child and adolescent psychiatry and a fellowship in biological psychiatry and psychopharmacology at hospitals affiliated with the Albert Einstein College of Medicine in New York.

Dr. Grosz has an extensive clinical experience with more than 20 years in practice. He held academic appointments at the Albert Einstein College of Medicine in New York and at the University of California in Los Angeles.

Dr. Grosz has been in private practice in the San Fernando Valley since 1992. In addition, he is the Director of Mental Health Services at Penny Lane Centers, a large organization helping children and adolescents in foster care and residential placement with offices throughout Los Angeles.

Dr. Grosz has also been involved in clinical research for more than 20 years. While in New York, he was Director of Research in Child and Adolescent Psychiatry at the Albert Einstein College of Medicine. Since 1997 he has been the Medical Director of the Pharmacology Research Institute, in Encino, California. At PRI, he has been a principal investigator for more than 100 clinical trials of new medications for depression, generalized and social anxiety disorders, bipolar disorder, and ADHD.

In the past several years, Dr. Grosz has been integrating to his practice, complementary psychiatric approaches such as nutritional supplements, guided imagery and hypnosis. He underwent training in Integrative Holistic Medicine and Natural Supplements sponsored by the Scripps Center for Integrative Medicine. He is currently certified by the American Board of Holistic Medicine.

For several years I have been interested in helping clients expand their human potential, overcome personal limitations, while educating them about the interconnectedness of the brain, the mind, the body, and consciousness.

Until not so long ago, neuroscience led us to believe that we were victims of our genetic make up and our early conditionings. When I was in medical school I was taught that once we became adults, our brains were hardwired, static and rigid. However, new paradigms in neuroscience suggest that our brain cells have several neuroprotective and growth factors that help them regenerate, suggesting that we have significant abilities to change, that each one of us is a work in progress, throughout our life. In fact, our brains have a natural ability called neuroplasticity, which means that if we learn new knowledge and have new experiences, we can develop new networks or circuits of neurons, and literally change our mind.

Every time we have a thought, different areas of our brain surge with electrical current and release different neurochemicals. Thanks to functional brain imaging technology, we can now see that our every thought and experience causes our brain cells, or neurons, to connect and disconnect in ever-changing patterns and sequences.

So, why is it hard for us to change? What happens is that we keep using the same patterns and combinations of neural circuits in our brain, and they tend to become hardwired.

This is how we create habits of thinking, feeling, and doing. But if we want to change something in our life, we have to cause the brain to no longer fire in the same old sequences and combinations. We have to create a new level of mind by disconnecting the old neural circuits and rewiring our brain in new patterns of nerve cell connections.

The good news we're learning from the latest brain research is that we can change the brain and thus change ourselves.

We are also learning more on the relationship between thoughts and the physical body?

An emerging scientific field called psychoneuroimmunology is demonstrating the connection between the mind and the body, and is beginning to help us understand the link between how we think and how we feel. We now know that our every thought produces a biochemical reaction in the brain. The brain then releases chemical signals that are transmitted to the body, where they act as messengers of the thought. In this way, the thoughts that produce these chemicals in the brain allow our body to feel exactly the way we were just thinking.

Essentially, when we have happy, inspiring, or positive thoughts, our brain manufactures chemicals that make us feel joyful, inspired, or uplifted. For example, when we look forward to a pleasurable experience, the brain immediately makes a chemical neurotransmitter called dopamine, which turns the brain and body on in anticipation of that experience, and we feel excited. If we have thoughts of hate, anger, or insecurity, the brain produces chemicals that the body responds to in a comparable way, and we feel hateful, angry, or unworthy. Another chemical called ACTH, signals the body to produce chemical secretions from the adrenal glands that make us feel threatened or aggressive.

When the body responds to a thought by having a feeling, the brain, which constantly monitors the status of the body, notices that the body is feeling a certain way. In response to that bodily feeling, the brain generates thoughts that produce corresponding chemical messengers, so that we begin to think the way we are feeling. Thinking creates feeling, and then feeling creates thinking, in a continuous biological feedback loop. This cycle eventually creates a particular state in the body—what we call a state of being—that determines the general nature of how we feel and behave.

There is significant scientific evidence suggesting that the mind has a direct effect on the body, both for better and for worse. Research demonstrates that we can cause our bodies to be sick just by the anticipation of a future event or the memory of a past experience. In both cases, it is our thoughts that are creating powerful chemicals of stress to alter most of the systems in our body. So what we think about and the intensity of these thoughts directly influences our health, the choices we make, and our quality of life.

Tuesdays 1-7 PM

Fridays 1-6 PM

Initial consultation: $300.

Holistic consultation: $400.

Follow up visits: $100.

Extended follow up: $200.

The principles of holistic medical practice are:

Optimal health is the primary goal of holistic medical practice. It is the conscious pursuit of the highest level of functioning and balance of the physical, environmental, mental, emotional, social and spiritual aspects of human experience, resulting in a dynamic state of being fully alive. This creates a condition of well-being regardless of the presence or absence of disease.

The Healing Power of Love. Holistic health care practitioners strive to meet the patient with grace, kindness, acceptance, and spirit without condition as love is life’s most powerful healer.

Whole person. Holistic health care practitioners view people as the unity of body, mind, spirit and the systems in which they live.

Prevention and treatment. Holistic health care practitioners promote health, prevent illness and help raise awareness of dis-ease in our lives rather than merely managing symptoms. A holistic approach relieves symptoms, modifies contributing factors, and enhances the patient’s life system to optimize future well-being.

Innate Healing Power. All people have innate powers of healing in their bodies, minds and spirits. Holistic health care practitioners evoke and help patients utilize these powers to affect the healing process.

Integration of Healing Systems. Holistic health care practitioners embrace a lifetime of learning about all safe and effective options in diagnosis and treatment. These options come from a variety of traditions, and are selected in order to best meet the unique needs of the patient. The realm of choices may include lifestyle modification and complementary approaches as well as conventional drugs and surgery.

Relationship-centered care. The ideal practitioner-patient relationship is a partnership which encourages patient autonomy, and values the needs and insights of both parties. The quality of this relationship is an essential contributor to the healing process.

Individuality. Holistic health care practitioners focus patient care on the unique needs and nature of the person who has an illness rather than the illness that has the person.

Teaching by Example. Holistic health care practitioners continually work toward the personal incorporation of the principles of holistic health, which then profoundly influence the quality of the healing relationship.

Learning opportunities. All life experiences including birth, joy, suffering and the dying process are profound learning opportunities for both patients and health care practitioners.

Reprinted with permission from the American Board of Holistic Medicine.

This is a questionnaire that I use as part of a comprehensive holistic assessment.

Answer the questions in each section below and total your score. Each response will be a number from 0 to 5. Please refer to the frequency described within the parentheses (e.g. 2 to 3 times a week) when answering questions about an activity; e.g. Do you maintain a healthy diet? However, when the question refers to an attitude or an emotion (most of the Mind and Spirit questions), e.g., Do you have a sense of humor? the response is more subjective, less exact, and you can refer only to the items describing the frequency, such as often or daily, but not to the numbered frequencies in parentheses.

0 = Never or almost never (once a year or less)

1 = Seldom (2 to 12 times a year)

2 = Occasionally (2 to 4 times a month)

3 = Often (2 to 3 times a week)

4 = Regularly (4 to 6 times a week)

5 = Daily (every day)

BODY: Physical and Environmental Health

1. Do you maintain a healthy diet: low fat, low sugar, fresh fruits, grains and vegetables? ____

2. Is your water intake adequate (at least ½ oz./lb. of body weight; 160 lbs. = 80 oz.)? ____

3. Are you within 20 percent of your ideal body weight ? ____

4. Do you feel physically attractive ? ____

5. Do you fall asleep easily and sleep soundly? ____

6. Do you awake in the morning feeling well rested? ____

7. Do you have more than enough energy to meet your daily responsibilities ? ____

8. Are your five senses acute ? ____

9. Do you take time to experience sensual pleasure ? ____

10. Do you schedule regular massage or deep-tissue body work ? ____

11. Does your sexual relationship feel gratifying ? ____

12. Do you engage in regular physical workouts lasting at least 20 minutes ? ____

13. Do you have good endurance or aerobic capacity ? ____

14. Do you breathe abdominally for at least a few minutes ? ____

15. Do you maintain physically challenging goals ? ____

16. Are you physically strong ? ____

17. Do you do some stretching exercises ? ____

18. Are you free of chronic aches, pains, ailments and diseases ? ____

19. Do you have regular effortless bowel movements ? ____

20. Do you understand the causes of your chronic physical problems ? ____

21. Are you free of any drug or alcohol dependency (including nicotine and caffeine) ? ____

22. Do you live in a healthy environment with respect to clean air, water and indoor pollution ? ____

23. Do you feel energized or empowered by nature ? ____

24. Do you feel a strong connection with and appreciation for your body, your home and your environment ? ____

25. Do you have an awareness of life-energy or qi ? ____

TOTAL BODY SCORE _________

MIND: Mental and Emotional Health

1. Do you have specific goals in your personal and professional life ? ____

2. Do you have the ability to concentrate for extended periods of time ? ____

3. Do you use visualization or mental imagery to help you attain your goals or enhance your performance ? ____

4. Do you believe it is possible to change ? ____

5. Can you meet your financial needs and desires ? ____

6. Is your outlook basically optimistic ? ____

7. Do you give yourself more supportive messages than critical messages ? ____

8. Does your job utilize all of your greatest talents ? ____

9. Is your job enjoyable and fulfilling ? ____

10. Are you willing to take risks or make mistakes in order to succeed ? ____

11. Are you able to adjust beliefs and attitudes as a result of learning from painful experiences? ____

12. Do you have a sense of humor ? ____

13. Do you maintain peace of mind and tranquility ? ____

14. Are you free from a strong need for control or the need to be right ? ____

15. Are you able to fully experience your painful feelings such as fear, anger, sadness, and hopelessness ? ____

16. Are you aware of and able to safely express fear ? ____

17. Are you aware of and able to safely express anger ? ____

18. Are you aware of and able to safely express sadness or cry ? ____

19. Are you accepting of all your feelings ? ____

20. Do you engage in meditation, contemplation, or psychotherapy to better understand your feelings ? ____

21. Is your sleep free from disturbing dreams ? ____

22. Do you explore the symbolism and emotional content of your dreams ? ____

23. Do you take the time to let down and relax? ____

24. Do you experience feelings of exhilaration ? ____

25. Do you enjoy high self-esteem ?

TOTAL MIND/EMOTIONS SCORE _________

SPIRIT: Spiritual and Social Health

1. Do you actively commit time to your spiritual life ? ____

2. Do you take time for prayer, meditation, or reflection ? ____

3. Do you listen to your intuition ? ____

4. Are creative activities a part of your work or leisure time ? ____

5. Do you take risks or exceed previous limits ? ____

6. Do you have faith in a God, spirit guides, or angels ? ____

7. Are you free from anger toward God ? ____

8. Are you grateful for the blessings in your life ? ____

9. Do you take walks, garden, or have contact with nature ? ____

10. Are you able to let go of your attachment to specific outcomes and embrace uncertainty ? ____

11. Do you observe a day of rest away from work, dedicated to nurturing yourself and your family ? ____

12. Can you let go of self-interest in deciding the best course of action for a given situation ? ____

13. Do you feel a sense of purpose ? ____

14. Do you make time to connect with young children, either your own or someone else's? ____

15. Are playfulness and humor important to you in your daily life ? ____

16. Do you have the ability to forgive yourself and others ? ____

17. Have you demonstrated the willingness to commit to a marriage or compatible long-term relationship ? ____

18. Do you experience intimacy, besides sex, in your committed relationships ? ____

19. Do you confide in or speak openly with one or more close friends ? ____

20. Do you or did you feel close to your parents ? ____

21. If you have experienced the loss of a loved one, have you fully grieved that loss ? ____

22. Has your experience of pain enabled you to grow spiritually ? ____

23. Do you go out of your way or give time to help others ? ____

24. Do you feel a sense of belonging to a group or community ? ____

25. Do you experience unconditional love ?

TOTAL SPIRIT SCORE _________

TOTAL BODY, MIND, SPIRIT SCORE _________

HEALTH SCALE

325 - 375 Optimal Health

275 - 324 Excellent Health

225 - 274 Good Health

175 - 224 Fair Health

125 - 174 Below Average Health

75 - 124 Poor Health

0 - 74 Extremely Poor Health = Surviving

Reprinted with permission from the American Board of Holistic Medicine.

SCIENTIFIC PUBLICATONS

1. Feldman, D., Grosz, D.E. and Agassi, R.: Short-term Group Psychotherapy for Soldiers: James Mann's Approach. Technical Report. Israel Defense Forces, Mental Health Center, 1985.

2. Grosz, D.E. and Szeibel, P.: The AECOM/MMC Adolescent Suicide Prevention Project for Bronx County. The Bulletin of Area II Council, American Psychiatric Association, Vol. 32, Number 3, November 1989.

3. Asnis G.M., Harkavy Friedman, J., Iqbal, N., Bajwa, W., Kalus, O., Rubinson, E., Grosz, D.E., van Praag, H.M. and Cooper, T.: The Drug Free Period: A Methodological Issue. Biological Psychiatry 27: 657-660, 1990.

4. Kalus, O., Asnis, G.M., Rubinson, E., Kahn, R., Harkavy Friedman, J.M., Iqbal, N., Grosz, D.E., van Praag, H.M. and Cahn, W.: Desipramine Treatment in Panic Disorder. Journal of Affective Disorders, Vol. 21 (4): 239-244, 1991.

5. Korn, M., Kotler, M., Molcho, A., Botsis, A., Grosz, D.E., Chen, C., Plutchik, R., Brown, S. and van Praag, H.M.: Suicide and Aggression Associated with panic Attacks. Biological Psychiatry, 31:607-612, 1992.

6. Korn, M.L., Botsis, A.J., Kotler, M., Plutchik, R., Conte, H.R., Finkelstein G., Grosz, D.E., Kay, S.R., Brown, S.L. and van Praag, H.M.: The SAS: A Semi-Structured instrument for the measurement of suicidality and aggression. Comprehensive Psychiatry, 33, 6:359-365, 1992.

7. Constantino, J.N., Grosz, D.E., Saenger, P., Chandler, D.W., Nandy, R., Earls, F.J.: Testosterone and aggression in children. J. Am. Acad. Child Adolesc. Psychiatry, 32, 6:1217-1222, 1993.

8. Fields, J.H., Grochowski, S., Lindenmayer, J.P., Kay, S.R., Grosz, D.E., Hyman, R.B. and Alexander, G.: Assessing positive and negative symptoms in children and adolescents. Am J Psychiatry 151:249-253, 1994

9. Grosz, D.E., Lipschitz, D.S., Eldar, S., Finkelstein, G., Blackwood, N., Gerbino-Rosen, G. and Plutchik, R.: Correlates of violence risk in hospitalized adolescents. Comprehensive Psychiatry, Vol. 35, 4:296-300, 1994.

10. Grosz, D.E.; Morrissey, J.L. and Wilcox, C.S.: Comparative Effectiveness of Triptans for the Treatment of Migraine. Today's Therapeutic Trends 20(2): 97-112, 2002.

11. Spierings, E.L.H., Gomez-Mancilla, B., Grosz, D.E., Rowland, C.R., Whaley, F.S. and Jirgens, K.J.: Oral Almotriptan vs Oral Sumatriptan in the Abortive Treatment of Migraine: A Double-blind, Randomized, Parallel-Group, Optimum-Dose Comparison. Archives of Neurology, 58: 944-950, June 2001.

BOOK CHAPTERS

1. D.E. Grosz, J.K. Zimmerman and G.M. Asnis: Suicidal Behaviors in Adolescents: A Review of Risk and Protective Factors, in Treatment Approaches with Suicidal Adolescents. J.K. Zimmerman, and G.M. Asnis (Eds) pp. 17-43, 1995. The Einstein Psychiatry Series. New York: John Wiley & Sons.

BOOK REVIEWS

l. L. Davidson, M. Linnoila (Eds). Risk Factors for Youth Suicide, New York Hemisphere; 1991. In Suicide and Life Threatening Behaviors, 23, 1:88-89, 1993.

SCIENTIFIC PRESENTATIONS

1. Grosz, D.E., Kotler, M. and Elizur, A.: Interactional Variables in Families of Schizophrenics. Presented at the 4th Israel Psychiatric Association Meetings, Safed. May 1984.

2. Koplewicz, H., Klass, E., Gittelman-Klein, R., Grosz, D.E., Oris, C., Marsh, J., Kovacs, M., Ryan, N. and Robins, D.: Topics in Adolescent Depression: Classification and Treatment. 35th Annual Meeting, American Academy of Child and Adolescent Psychiatry. Seattle, Washington. October 1988.

3. Dech, B., Schnek, A., Grosz, D.E., Szeibel, P., Turner, S., Abikoff, H. and Koplewicz, H.: The Ideal Training Program and Satisfaction with Training: A Survey of Child Psychiatry Fellows. New Research. 35th Annual Meeting, American Academy of Child and Adolescent Psychiatry. Seattle, Washington. October 1988.

4. Grosz, D.E., Asnis, G.M., Harkavy Friedman, J., Zimmerman, J., van Praag, H.M. and Lemle, L.: Preliminary Findings of a New Teen Suicide Program. New Research Poster Session, American Psychiatric Association Annual Meeting. San Francisco, California. May 1989.

5. Kalus, O., Asnis, G.M., Cahn, W., Rubinson, E., Harkavy Friedman, J. and Grosz, D.E.: Varying Response to Desipramine in Panic Disorder. New Research Poster Session, American Psychiatric Association Annual Meeting. San Francisco, California. May 1989.

6. Grosz, D.E.: Suicide in the Israel Defense Forces: Approaches at Treatment and Prevention. Paper presented at the conference Adolescent and Young Adult Suicide in the United States and Israel. A Cross Cultural Perspective. Boston, Massachusetts. February 11, 1990.

7. Grosz, D.E., Asnis, G.M., Harkavy Friedman, J., Kausar, S., Zimmerman, J. and van Praag, H.M.: The Fenfluramine Challenge in Depressed Adolescents. New Research Poster Session, American Psychiatric Association 143rd Annual Meeting. New York, New York. May 14, 1990.

8. Kotler, M., Molcho, A., Apter, A., Plutchik, R., Brown, S.L., van Praag, H.M. and Grosz, D.E.: Coping Styles in Suicide and Violence. Paper presented at the American Psychiatric Association 143rd Annual Meeting. New York, New York. May 15, 1990.

9. Grosz, D.E.: Phenomenology and Diagnosis of Mood Disorders. Paper presented at the symposium: Mood disorders throughout the life cycle. Albert Einstein College of Medicine/Bronx-Lebanon Hospital Center. Bronx, New York. June 29, 1990.

10. Grosz, D.E.: The Fenfluramine Challenge in Depressed Adolescents. New Research Poster Session, German/American Psychiatric Association Joint Meeting. Bad Kissigen, Germany. September 6, 1990.

11. Grosz, D.E.: Serotonin in Aggressive Behavior: Experimental Findings and Hypotheses. Paper presented at the symposium: Aggressive Behavior in Children and Adolescents: Biological and Psychological Aspects. American Academy of Child and Adolescent Psychiatry 37th Annual Meeting. Chicago, Illinois. October 25, 1990.

12. Grosz, D.E., Asnis, G.M., Harkavy Friedman, J., Kausar, S., Zimmerman, J. and van Praag, H.M.: Serotonergic Responsivity in Suicidal Adolescents. New Research Poster Session, American Academy of Child and Adolescent Psychiatry 37th Annual Meeting. Chicago, Illinois. October 26, 1990.

13. Grosz, D.E., Blackwood, N., Finkelstein, G. and Plutchik, R.: Correlates of Suicide Risk in Adolescent Inpatients. Paper presented at the American Association of Suicidology 24th Annual Conference. Boston, Massachusetts. April 20, 1991.

14. Grosz, D.E., Kisnad, H. and Sokol, M.: Biological and Psychopharmacological Approaches in the Understanding and Treatment of Aggressive Behavior. Workshop presented at the symposium Aggressive and Violent Behavior in Children and Adolescents. The New York Hospital Cornell Medical Center - Westchester Division, White Plains, New York. May 2, 1991.

15. Eldar S., Finkelstein, G., Lipschitz, D., Grosz, D.E. and Plutchik, R.: Correlates of Violence Risk in Hospitalized Adolescents. New Research Poster Session, American Psychiatric Association 144th Annual Meeting. New Orleans, Louisiana. May 13, 1991.

16. Fields, J.F., Kay, S., Alexander, G., Grochowski, S., Grosz, D.E., Lindenmeyer, J.P., Pawl, G., Reyes, A. and Leven, L.: A Positive and Negative Symptom Scale for Children and Adolescents: A Study of Criterion Validity and Interrater Reliability. New Research Poster Session, American Psychiatric Association 144th Annual Meeting. New Orleans, Louisiana. May 14, 1991.

17. Grosz, D.E., Asnis, G.M., Harkavy Friedman, J., Elder, S., Adel, L., Zimmerman, J.K. and van Praag, H.M.: Biological Risk Factors in Adolescent Suicide. Paper presented at the symposium: Youth Suicide: Update on Risk Factors and Treatment (Grosz, D.E., and Asnis, G.M., Chairpersons). American Psychiatric Association 144th Annual Meeting. New Orleans, Louisiana. May 14, 1991.

18. Fields, J.F., Kay, S., Grosz, D.E., Hyman, R.B., Grochowski, S. and Lindenmeyer, J.P.: Assessing Positive and Negative Symptoms in Children and Adolescents. New Research Poster Session, 38th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. San Francisco, California. October 17, 1991.

19. Grosz, D.E., Eldar, S., Finkelstein, G., Wetzler, S. and Gerbino-Rosen, G.: The SCID-II in the Assessment of Personality Disorders in Adolescents. New Research Poster Session, 38th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. San Francisco, California. October 19, 1991.

20. Wilcox, C.S., Morrissey, J.L., Heiser, J.F., Katz, B.B., Cho, F.E., Grosz, D.E., Linden, R.D. and DeFrancisco, D.F. Patients Motivations as Potential Predictors of Placebo Response. Yesterday and Today. 37th Annual Meeting, American College of Neuropsychopharmacology, Las Croabas, Puerto Rico. December 14, 1998.

21. Wilcox, C.S., Cho, F.E., Heiser, J.F., Morrissey, J.L., Katz, B.B., Grosz, D.E. and DeFrancisco, D.F. Placebo Response in Depression Studies: Do Previously Reported Predictors Have Any Utility? 39th Annual N.C.D.E.U. Meeting, Boca Raton, Florida. June 2, 1999.

22. Wilcox, C.S., Morrissey, J.L., Heiser, J.F., Katz, B.B., Schneider, A.L., Delaney, J.E. and Grosz, D.E. Profiling Migraineurs as Research Subjects: Pharmacoeconomic and Quality of Life Measures. 38th Annual American College of Neuropsychopharmacology (A.C.N.P.) Meeting, Acapulco, Mexico. December 14, 1999.

23. Spierings, E.L.H., Gomez-Mancilla, B., Grosz, D.E., Rowland, C.R., Whaley, F.S., Jirgens, K.J., McShane, M.M. and Klobucar, T.R. Oral Almotriptan vs. Oral Sumatriptan in a Double-Blind, Randomized, Parallel-Group Study of Quality of Life and Health Economics in Migraine Patients. Accepted for Presentation, American Academy of Neurology, AAN Annual Meeting, San Diego, California. May 3, 2000.

24. Wilcox, C.S., Morrissey, J.L., Heiser, J.F., Cho, F.E., Katz, B.B., Mijares, C.P. and Grosz, D.E. Major Depressive Disorders and Migraine Headaches: Is Comorbidity a Serious Threat to Homogeneity? 40th Annual N.C.D.E.U. Meeting, Boca Raton, Florida. May 31, 2000.

25. Spierings, E., Gomez-Mancilla, B., Grosz, D.E., Rowland, C.R., Whaley, F.S. and Jirgens, K.J. Oral Almotriptan vs. Oral Sumatriptan in a Double-Blind, Randomized, Parallel-Group Study of Quality of Life and Health Economics in Migraine Patients. Accepted for Presentation, 42nd Annual Scientific Meeting of the American Headache Society (AHS), Montreal, Quebec, Canada. June 24, 2000.

26. Wilcox, C.S.; Morrissey, J.L.; Cho, F.E.; Heiser, J.F.; Katz, B.B.; Janko, S.E.; Grosz, D.E. and DeFrancisco, D.F. Profiling Social Anxiety Disorder Research Subjects: An Evaluation of Symptom Severity, Quality of Life and Overall Representativeness. 39th Annual American College of Neuropsychopharmacology (A.C.N.P.) Meeting, San Juan, Puerto Rico, December 11, 2000.

27. Wilcox, C.S.; Morrissey, J.L.; Cho, F.E.; Grosz, D.E.; Katz, B.B.; Janko, S.E.; Puppione, A.A. and Heiser, J.F. The Effects of Gender and Methodology on Homogeneity and Outcomes in Clinical Trials: A Look at Social Anxiety Disorder Research Volunteers. 41st Annual N.C.D.E.U. Meeting, Phoenix, Arizona, May 30, 2001.

28. Grosz, D.E.; Morrissey, J.L. and Wilcox, C.S. Almotriptan is Effective for Multiple Migraine Attacks. 10th International Headache Congress, New York, New York, June 30, 2001.

29. Wilcox, C.S.; Heiser, J.F.; Morrissey, J.L.; Grosz, D.E.; Cho, F.E.; Katz, B.B.; Janko, S.E. and Linden, R.D. Protocol Design and Predictors of Placebo Response in Anxiety Disorders: Generalized Anxiety Disorder vs. Social Anxiety Disorder. 40th Annual American College of Neuropsychopharmacology (A.C.N.P.) Meeting, Waikoloa, Hawaii, December 10, 2001.

30. Wilcox, C.S.; Morrissey, J.L.; Heiser, J.F.; Cho, F.E.; Grosz, D.E.; Katz, B.B. and DeFrancisco, D.F. Venlafaxine-ER vs. Placebo in Adults with Generalized Social Anxiety Disorder. 41st Annual American College of Neuropsychopharmacology (A.C.N.P.) Meeting, San Juan, Puerto Rico, December 11, 2002.

31. Wilcox, C.S.; Morrissey, J.L.; Cho, F.E.; Heiser, J.F.; Katz, B.B.; Grosz, D.E.; Tong, M. and DeFrancisco, D. Placebo Response and Social Anxiety Disorder: What Happened to Reliable Predictors?. 43rd Annual NCDEU Meeting, Boca Raton, Florida, May 28, 2003.

32. Wilcox, C.S.; Katz, B.B.; Heiser, J.F.; Cho, F.E.; Morrissey, J.L.; Grosz, D.E.; Hardy, A.I.; DeFrancisco, D.F. Placebo Response and Anxiety Disorders: A Critical Evaluation of Influential Variables. 16th European College of Neuropsychopharmacology (E.C.N.P.) Congress, Prague, Czech Republic, September 23, 2003.

33. Wilcox, C.S.; Katz, B.B.; Heiser, J.F.; Hardy, A.I.; Cho, F.E.; Adkins, D.M.; Morrissey, J.L. and Grosz, D.E. Profiling Smoking Cessation Research Subjects: Demographic and Baseline Characteristics as Predictors of Retention/Completion. 42nd Annual American College of Neuropsychopharmacology (A.C.N.P.) Meeting, San Juan, Puerto Rico, December 9, 2003.

34. Wilcox, C.S.; Morrissey, J.L.; Hardy, A.I.; Heiser, J.F.; Katz, B.B.; Adkins, D.M.; Tong, M. and Grosz, D.E. Predictors of Success in Smoking Cessation Studies: An Analysis of Socioeconomic, Behavioral and Demographic Variables. 43rd Annual American College of Neuropsychopharmacology (A.C.N.P.) Meeting, San Juan, Puerto Rico, December 15, 2004.

35. Wilcox, C.S.; Heiser, J.F.; Katz, B.B.; Thach, A.L.; Henry, M.M.; Cooper, M.E.; Oskooilar, N.; Morrissey, J.L. and Grosz, D.E. Behavioral, Demographic and Socioeconomic Variables as Potential Predictors of Successful Smoking Cessation, Vis-Ã -Vis a Clinical Trial. 11th Annual Society for Research on Nicotine and Tobacco (S.R.N.T.) Meeting [and Joint 7th Annual SRNT European Conference], Prague, The Czech Republic, March 21, 2005.

36. Wilcox, C.S.; Oskooilar, N.; Katz, B.B.; Grosz, D.E.; Morrissey, J.L.; Henry, M.M. and De Francisco, D.F. Pharmacologies from the Atypical Depression Study Participants Perspective. 46th Annual NCDEU Meeting, Boca Raton, Florida, June 14, 2006.

37. Wilcox, C.S.; Heiser, J.F.; Katz, B.B.; Oskooilar, N.; Henry, M.M.; Grosz, D.E.; Morrissey, J.L.; Noble, E.P. and De Francisco, D.F. A Double-Blind Study Comparing Varenicline with Bupropion-SR and Placebo for Smoking Cessation: Results from a Single Center. 45th Annual American College of Neuropsychopharmacology (A.C.N.P.) Meeting, Hollywood, Florida, December 4, 2006.